Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Investigational New Drugs
|
March 7, 2018
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Herbert Hurwitz, Eric Van Cutsem, Johanna Bendell, et al.
World Journal of Gastroenterology
|
March 6, 2015
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
Jonathan R Strosberg, George A Fisher, Al B Benson, et al.
Pancreas
|
December 6, 2012
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi process
Jonathan R Strosberg, George A Fisher, Al B Benson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Investigational New Drugs
|
March 7, 2018
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Herbert Hurwitz, Eric Van Cutsem, Johanna Bendell, et al.
World Journal of Gastroenterology
|
March 6, 2015
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
Jonathan R Strosberg, George A Fisher, Al B Benson, et al.
Pancreas
|
December 6, 2012
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi process
Jonathan R Strosberg, George A Fisher, Al B Benson, et al.
Page
of 2